期刊文献+

西格列汀联合二甲双胍治疗磺脲类药物失效的老年糖尿病效果观察 被引量:5

Observation on the Effect of Sitagliptin Combined with Metformin in the Treatment of Senile Diabetes Mellitus with Sulfonylurea Drug Failure
下载PDF
导出
摘要 目的:总结并归纳西格列汀联合二甲双胍治疗磺脲类药物失效的老年糖尿病效果。方法:本文挑选2017年4月-2018年4月笔者所在医院80例磺脲类药物失效的老年糖尿病患者,将其纳入本研究。采用计算机表法将患者分为对照组和观察组,分别40例。对照组接受优泌乐(赖脯胰岛素注射液)皮下注射治疗,观察组采用西格列汀联合二甲双胍治疗。治疗3个月后,比较两组临床治疗效果及治疗前后餐后2 h血糖和糖化血红蛋白水平。结果:治疗后,观察组治疗效果、餐后2 h血糖和糖化血红蛋白水平均远优于对照组,差异有统计学意义(P<0.05)。结论:在磺脲类药物失效的老年糖尿病治疗中,西格列汀联合二甲双胍具有更高的治疗效果,可有效改善血糖水平,改善预后。 Objective:To summarize and sumup the effect of Sitagliptin combined with Metformin in the treatment of senile diabetes mellitus with Sulfonylurea drug failure.Method:From April 2017 to April 2018,80 elderly diabetic patients with Sulfonylurea drug failure were selected and included in this study.The patients were divided into the control group and the observation group by computer table method,40 patients respectively.Patients in the control group were treated with subcutaneous injection of Lispro(Recombinant Human Insulin Lispro Injection),while patients in the observation group were treated with Sitagliptin combined with Metformin.After one month of treatment,the clinical therapeutic effects of the two groups and 2-hour post-meal blood glucose and glycated blood glucose levels before and after treatment were compared.Result:After treatment,the observation group were far better than the control group in terms of therapeutic effect,2-hour post-meal blood glucose and glycated blood sugar level(P<0.05).Conclusion:Sitagliptin combined with Metformin has a higher therapeutic effect in the treatment of elderly diabetic patients with sulfonylurea drug failure,which can effectively improve the blood glucose level of patients and improve the prognosis of patients.
作者 汪琴 黄延志 WANG Qin;HUANG Yanzhi(Xuan’en County People’s Hospital,Xuan’en 445500,China)
机构地区 宣恩县人民医院
出处 《中外医学研究》 2019年第20期117-119,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 西格列汀 二甲双胍 磺脲类 糖尿病 Sitagliptin Metformin Sulfonylureas Diabetes mellitus
  • 相关文献

参考文献15

二级参考文献103

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 2姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 3Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease[J]. Cell, 2010, 140(6): 900- 917. DOI: 10.1016/j.cell.2010.02.034.
  • 4Monnier L, Colette C. Glycemic variability: should we and can we prevent it?[J]. Diabetes Care, 2008, 31 Suppl 2: S150-154. DOI: 10.2337/dc08-s241.
  • 5van Genugten RE, van Raahe DH, Diamant M. Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence[J]. Diabetes Obes Metab, 2012, 14(2): 101-411. DOI: 10.1111/j.1463-1326. 2011. 01473.x.
  • 6Barbieri M, Rizzo MR, Marfella R, et al. Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors[J]. Atherosclerosis, 2013, 227(2): 349- 354. DOI: 10.1016/j. atherosclerosis.2012.12.018.
  • 7Cho YM, Kieffer TJ. K-cells and glucose-dependent insulinotropic polypeptide in health and disease[J]. Vitam Horm, 2010, 84: 111- 150. DOI: 10.1016/B978-0-12-381517-0.00004-7.
  • 8Drucker DJ,Nauck MA.The incretin system:glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes[J].Lancet,2006,368(9548):1696-1705.
  • 9Lvanon KP,Mychka VB.Perspectives of impaired glucose tolerance management in patients with metabolic syndrome[J].Cardiovasc Ther Prevention,2011,10:77-82.
  • 10Van Poppel PC,Netea MG,Smits P,et al.Vildagliptin improves endothelium-dependent vasodilatationin type 2 diabetes[J].Diabetes Care,2011,34:2072-2077.

共引文献432

同被引文献35

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部